Daniel Wynn, MD
Enriched profileDirector of Clinical Research, Consultants in Neurology Ltd. · Consultants in Neurology Ltd.
Daniel Wynn is Director of Clinical Research, Consultants in Neurology Ltd. at Consultants in Neurology Ltd.. OpenAlex indexes 68 publications with 5,788 citations (h-index 32); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 14 Oct 2026
Overview
Updated 15 Oct 2026
Daniel Wynn, M.D., is Director of Clinical Research, Consultants in Neurology Ltd.. The public record shows 68 publications with 5,788 citations (h-index 32), centered on Multiple Sclerosis Research Studies, Polyomavirus and related diseases, Chronic Lymphocytic Leukemia Research. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 82 companies.
- Most recent indexed publication: 2019 · Multiple sclerosis international
- Top research focus: Multiple Sclerosis Research Studies
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 82 companies
Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 42.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 15 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis
Sponsor: Acorda Therapeutics
- Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis
Sponsor: PDL BioPharma, Inc.
Industry payments
Updated 15 Oct 2026
82 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- EMD Serono, Inc.Program year202528 payments$22,579openpaymentsdata.cms.gov ↗
- E.R. Squibb & Sons, L.L.C.Program year20256 payments
- Vanda Pharmaceuticals Inc.Program year202528 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
66.6%SSRI9.7%Escitalopram Oxalate52%Sertraline Hcl21%Paroxetine Hcl12%Trazodone Hcl11%Fluoxetine Hcl6%Part D<11 patientsOther antiepileptics6.2%Topiramate57%Levetiracetam26%Lacosamide17%Part D<11 patients+ 22 more classes in this area
Cancer & immunology
18.7%Pyrimidine Synthesis Inhibitor6.3%Teriflunomide89%Aubagio11%Part D<11 patientsOther immunostimulants6.1%Copaxone38%Glatiramer Acetate33%Glatopa29%Part D<11 patients+ 4 more classes in this area
Musculoskeletal
11.9%gamma-Aminobutyric Acid-ergic Agonist7.7%Baclofen100%Part D≥46 patientsCentral alpha-2 Adrenergic Agonist3%Tizanidine Hcl100%Part D≥21 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 15 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Enduring Clinical Value of Copaxone® (Glatiramer Acetate) in Multiple Sclerosis after 20 Years of Use.
Multiple sclerosis international
Review2019
Most-cited works
by citation count (OpenAlex)- 01Natalizumab plus Interferon Beta-1a for Relapsing Multiple SclerosisArticle1,344 citations2006
- 02
- 03Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar AffectArticle370 citations2010
- 04The incidence and significance of anti-natalizumab antibodiesArticle339 citations2007
- 05
Network
Updated 15 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 15 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Residency in Internal Medicine
Neurology, EEG, EMG, and Sleep Disorders Medicine, Mayo Graduate School of Medicine
1987provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →webmd.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →webmd.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →webmd.com ↗
- Board Certification in Neurology
American Board of Psychiatry and Neurology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →webmd.com ↗ - Board Certification in Clinical Neurophysiology and EEG
EMG and Neuromuscular Disease
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →webmd.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →webmd.com ↗
- Certification
American College of Forensic Examiners
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →webmd.com ↗
Editorial & leadership roles
journal and society appointments- Member
American Academy of Neurology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →webmd.com ↗ - Fellow
American Clinical Neurophysiology Society
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →webmd.com ↗ - Fellow
American Board of Sleep Disorders Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →webmd.com ↗ - Member
American Epilepsy Society
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →webmd.com ↗ - Member
American Pain Society
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →webmd.com ↗ - Co-director
Consultants in Neurology Multiple Sclerosis Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →webmd.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →endeavorhealth.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Jorge Cortes, MD
University of Alabama at Birmingham (UAB)
Ayalew Tefferi, MD
Mayo Clinic
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center